Please log in
You must be logged in to send the contact request.
Manage stand orders
Select Option
M MONITOR INC
Room 1034, 62, Seongseogongdan-ro 11-Gil, Dalseo-gu,
42713
Daegu
Korea, Republic
Korea, Republic
Submit your contact details
Provide your contact details to the exhibitor. Optionally, you may also add a personal message.
An error has occurred
Please check your internet connection or try again later.
Message has been sent
Your message to the exhibitor was sent successfully.
Contact
Hyejin Jung
Business Development
Jack Younghun Kim
Senior Director
Business Development
Business Development
Visit us
16.11.2020
Topic
all-day
A fast, efficient and simple test that wall wanted!
M monitor introduces a real advance in point-of-care molecular diagnostics of SARS-CoV-2 virus that is radically faster, cheaper, and more reliable than the conventional methods.
Our COVID-19 detection kit is a diagnostic kit that detects SARS-CoV-2 virus based on the newest patent technology, LAMP (Loop-mediated isothermal amplification). And we developed two types of diagnostic kits; real-time type for high accuracy and premixed type for easy to use.
Our COVID-19 detection kit is a diagnostic kit that detects SARS-CoV-2 virus based on the newest patent technology, LAMP (Loop-mediated isothermal amplification). And we developed two types of diagnostic kits; real-time type for high accuracy and premixed type for easy to use.
all-day
Actualize NEW types of MDx
M monitor Inc., is one of the leading companies with high technologies based on nucleic acid isothermal amplification platform.
We develops and produces reagents and instruments for molecular diagnosis as well as reasearch field. Our diagnostic products lead the paradigm of diagnosis in accuracy and speed aspects by combining with the advantages of both immuno-chmical diagnosis and molecular diagnostic methods.
New patadigm of MDx is based on big 2 advantages of our core technology.
1. Reverse transcriptase and DNA polymerase and the reaction take place under a constant temperature.
2. High specificity because of designed specific primers to be compatabile with the target RNA.
M monitor is leaping forward as a global molecular diagnosis company based on various product pipelines and innovation.
We develops and produces reagents and instruments for molecular diagnosis as well as reasearch field. Our diagnostic products lead the paradigm of diagnosis in accuracy and speed aspects by combining with the advantages of both immuno-chmical diagnosis and molecular diagnostic methods.
New patadigm of MDx is based on big 2 advantages of our core technology.
1. Reverse transcriptase and DNA polymerase and the reaction take place under a constant temperature.
2. High specificity because of designed specific primers to be compatabile with the target RNA.
M monitor is leaping forward as a global molecular diagnosis company based on various product pipelines and innovation.
17.11.2020
Topic
all-day
A fast, efficient and simple test that wall wanted!
M monitor introduces a real advance in point-of-care molecular diagnostics of SARS-CoV-2 virus that is radically faster, cheaper, and more reliable than the conventional methods.
Our COVID-19 detection kit is a diagnostic kit that detects SARS-CoV-2 virus based on the newest patent technology, LAMP (Loop-mediated isothermal amplification). And we developed two types of diagnostic kits; real-time type for high accuracy and premixed type for easy to use.
Our COVID-19 detection kit is a diagnostic kit that detects SARS-CoV-2 virus based on the newest patent technology, LAMP (Loop-mediated isothermal amplification). And we developed two types of diagnostic kits; real-time type for high accuracy and premixed type for easy to use.
all-day
Actualize NEW types of MDx
M monitor Inc., is one of the leading companies with high technologies based on nucleic acid isothermal amplification platform.
We develops and produces reagents and instruments for molecular diagnosis as well as reasearch field. Our diagnostic products lead the paradigm of diagnosis in accuracy and speed aspects by combining with the advantages of both immuno-chmical diagnosis and molecular diagnostic methods.
New patadigm of MDx is based on big 2 advantages of our core technology.
1. Reverse transcriptase and DNA polymerase and the reaction take place under a constant temperature.
2. High specificity because of designed specific primers to be compatabile with the target RNA.
M monitor is leaping forward as a global molecular diagnosis company based on various product pipelines and innovation.
We develops and produces reagents and instruments for molecular diagnosis as well as reasearch field. Our diagnostic products lead the paradigm of diagnosis in accuracy and speed aspects by combining with the advantages of both immuno-chmical diagnosis and molecular diagnostic methods.
New patadigm of MDx is based on big 2 advantages of our core technology.
1. Reverse transcriptase and DNA polymerase and the reaction take place under a constant temperature.
2. High specificity because of designed specific primers to be compatabile with the target RNA.
M monitor is leaping forward as a global molecular diagnosis company based on various product pipelines and innovation.
18.11.2020
Topic
all-day
A fast, efficient and simple test that wall wanted!
M monitor introduces a real advance in point-of-care molecular diagnostics of SARS-CoV-2 virus that is radically faster, cheaper, and more reliable than the conventional methods.
Our COVID-19 detection kit is a diagnostic kit that detects SARS-CoV-2 virus based on the newest patent technology, LAMP (Loop-mediated isothermal amplification). And we developed two types of diagnostic kits; real-time type for high accuracy and premixed type for easy to use.
Our COVID-19 detection kit is a diagnostic kit that detects SARS-CoV-2 virus based on the newest patent technology, LAMP (Loop-mediated isothermal amplification). And we developed two types of diagnostic kits; real-time type for high accuracy and premixed type for easy to use.
all-day
Actualize NEW types of MDx
M monitor Inc., is one of the leading companies with high technologies based on nucleic acid isothermal amplification platform.
We develops and produces reagents and instruments for molecular diagnosis as well as reasearch field. Our diagnostic products lead the paradigm of diagnosis in accuracy and speed aspects by combining with the advantages of both immuno-chmical diagnosis and molecular diagnostic methods.
New patadigm of MDx is based on big 2 advantages of our core technology.
1. Reverse transcriptase and DNA polymerase and the reaction take place under a constant temperature.
2. High specificity because of designed specific primers to be compatabile with the target RNA.
M monitor is leaping forward as a global molecular diagnosis company based on various product pipelines and innovation.
We develops and produces reagents and instruments for molecular diagnosis as well as reasearch field. Our diagnostic products lead the paradigm of diagnosis in accuracy and speed aspects by combining with the advantages of both immuno-chmical diagnosis and molecular diagnostic methods.
New patadigm of MDx is based on big 2 advantages of our core technology.
1. Reverse transcriptase and DNA polymerase and the reaction take place under a constant temperature.
2. High specificity because of designed specific primers to be compatabile with the target RNA.
M monitor is leaping forward as a global molecular diagnosis company based on various product pipelines and innovation.
19.11.2020
Topic
all-day
A fast, efficient and simple test that wall wanted!
M monitor introduces a real advance in point-of-care molecular diagnostics of SARS-CoV-2 virus that is radically faster, cheaper, and more reliable than the conventional methods.
Our COVID-19 detection kit is a diagnostic kit that detects SARS-CoV-2 virus based on the newest patent technology, LAMP (Loop-mediated isothermal amplification). And we developed two types of diagnostic kits; real-time type for high accuracy and premixed type for easy to use.
Our COVID-19 detection kit is a diagnostic kit that detects SARS-CoV-2 virus based on the newest patent technology, LAMP (Loop-mediated isothermal amplification). And we developed two types of diagnostic kits; real-time type for high accuracy and premixed type for easy to use.
all-day
Actualize NEW types of MDx
M monitor Inc., is one of the leading companies with high technologies based on nucleic acid isothermal amplification platform.
We develops and produces reagents and instruments for molecular diagnosis as well as reasearch field. Our diagnostic products lead the paradigm of diagnosis in accuracy and speed aspects by combining with the advantages of both immuno-chmical diagnosis and molecular diagnostic methods.
New patadigm of MDx is based on big 2 advantages of our core technology.
1. Reverse transcriptase and DNA polymerase and the reaction take place under a constant temperature.
2. High specificity because of designed specific primers to be compatabile with the target RNA.
M monitor is leaping forward as a global molecular diagnosis company based on various product pipelines and innovation.
We develops and produces reagents and instruments for molecular diagnosis as well as reasearch field. Our diagnostic products lead the paradigm of diagnosis in accuracy and speed aspects by combining with the advantages of both immuno-chmical diagnosis and molecular diagnostic methods.
New patadigm of MDx is based on big 2 advantages of our core technology.
1. Reverse transcriptase and DNA polymerase and the reaction take place under a constant temperature.
2. High specificity because of designed specific primers to be compatabile with the target RNA.
M monitor is leaping forward as a global molecular diagnosis company based on various product pipelines and innovation.
Our range of products
Product categories
- 03 Diagnostic tests
- 03.06 Genetic testing, molecular diagnostics
- 03.06.03 Polymerase chain reaction (PCR)
Polymerase chain reaction (PCR)
Our products
Product category: Polymerase chain reaction (PCR)
A fast, efficient and simple test that wall wanted!
M monitor introduces a real advance in point-of-care molecular diagnostics of SARS-CoV-2 virus that is radically faster, cheaper, and more reliable than the conventional methods.
COVID-19 detection kit is a diagnostic kit that detects SARS-CoV-2 virus based on the newest patent technology, LAMP (Loop-mediated isothermal amplification). And we developed two types of diagnostic kits; real-time type for high accuracy and premixed type for easy to use.
COVID-19 detection kit is a diagnostic kit that detects SARS-CoV-2 virus based on the newest patent technology, LAMP (Loop-mediated isothermal amplification). And we developed two types of diagnostic kits; real-time type for high accuracy and premixed type for easy to use.
Product category: Polymerase chain reaction (PCR)
A complete kit with all you need!
CHECK H.pylori infection and Clarithromycin resistance al once!
The association between H.pylori and gastric cancer has attracted great interest worldwide. Gastric cancer is one of the most common malignancies in the world, although the incidence and mortality rate have benn decreasing in recent decades.
Isopollo H.pylori & CkaR has 4 big advantages.
1. Accurate: High accuracy based on molecular diagnostic method.
2. Fast: Diagnosis within 1 hour by simplified nucleic acid extraction system and isothermal amplification technology.
3. Compatibility: A wide range of thermocycler compatibility such as conventional or real-time machines.
4. Simple: The results are simply confirmed by color change, and no need to additional experiments or devices.
The association between H.pylori and gastric cancer has attracted great interest worldwide. Gastric cancer is one of the most common malignancies in the world, although the incidence and mortality rate have benn decreasing in recent decades.
Isopollo H.pylori & CkaR has 4 big advantages.
1. Accurate: High accuracy based on molecular diagnostic method.
2. Fast: Diagnosis within 1 hour by simplified nucleic acid extraction system and isothermal amplification technology.
3. Compatibility: A wide range of thermocycler compatibility such as conventional or real-time machines.
4. Simple: The results are simply confirmed by color change, and no need to additional experiments or devices.
Product category: Polymerase chain reaction (PCR)
A total diagnosis solution for Respiratory track infection!
All duagnosis start at 1 platform technology.
Respiratory infections caused by dozens of respiratory viral and bacterial pathogens commonly occur in symptomatic adult and pediatric patients. In particular, influenza viruses occur all over the world and affect millions of people every year for all ages. Influenza virus is mainly transmitted by the respiratory secretions of an infected person.
Isopollo Influenza A&B based on isothermal amplification technology help to ensure the best possible treatment to provides a fast and accurate diagnpsis.
You can experience 3 BIG advantages using our kit.
Respiratory infections caused by dozens of respiratory viral and bacterial pathogens commonly occur in symptomatic adult and pediatric patients. In particular, influenza viruses occur all over the world and affect millions of people every year for all ages. Influenza virus is mainly transmitted by the respiratory secretions of an infected person.
Isopollo Influenza A&B based on isothermal amplification technology help to ensure the best possible treatment to provides a fast and accurate diagnpsis.
You can experience 3 BIG advantages using our kit.
- Individual pouch packaging for personal diagnosis
- No need for conventional lab tools
- Use of cheap, small and battary controlled isothermal amplifiers
Product category: Polymerase chain reaction (PCR)
A Fast, Cheap, and Reliable test for mosquito-borne diseases is on the way to you.
“Current diagnostic reagents based on antigen-antibody reaction show a positive reaction (infected) in people who have been cured of mosquito-borne diseases or a negative response in people who have mosquito-borne diseases. – WHO (World Health Organization)
To prevent increased fatality rate from false result, we provide a variety of gene detection kits that can check the safety of threats from mosquito-borne viral diseases.
To prevent increased fatality rate from false result, we provide a variety of gene detection kits that can check the safety of threats from mosquito-borne viral diseases.
- ACCURATE: More than 99% accuracy based on molecular diagnostic method.
- FAST: Diagnosis within 1 hour by simplified nucleic acid extraction system and isothermal amplification technology.
- SIMPLE: The results are simply confirmed by color change, and no need to additional experiments or devices.
- COMPATIBILITY: A wide range of thermocycler compatibility such as conventional or real-time machines.
- Isopollo® Dengue test kit: qualitatively detects the presence of Dengue virus in human serum or whole blood.
- Isopollo® DENV (Serotype) detection kit: qualitatively analyzes each 4 types (DENV-1, DENV-2, DENV-3, DENV-4) of Dengue viruses in human serum or whole blood.
- Isopollo® Malaria (Pf/Pv) detection kit: qualitatively analyzes Plasmodium falciparum and Plasmodium vivax in whole blood.
- Isopollo® CHIKV detection kit: qualitatively detects the presence of Chikungunya virus in human serum or whole blood.
- Isopollo® ZIKV detection kit: qualitatively detects the presence of Zika virus in whole blood.
Product category: Polymerase chain reaction (PCR)
Mmiso® FMDV pan detection kit (For animal health)
Foot-and-mouth disease virus (FMDV) is the pathogen that causes foot-and-mouth disease. It is a picornavirus, the prototypical member of the genus Aphthovirus. The disease, which causes vesicles (blisters) in the mouth and feet of cattle, pigs, sheep, goats, and other cloven-hoofed animals is highly infectious and a major plague of animal farming.
Mmiso® FMDV pan detection kit is designed to amplify three serotypes : O, A, and Asia1 of the foot and mouth disease virus under isothermal conditions.
There are 3 big key advantages.
Mmiso® FMDV pan detection kit is designed to amplify three serotypes : O, A, and Asia1 of the foot and mouth disease virus under isothermal conditions.
There are 3 big key advantages.
- High specificity: Due to using 6 distinct primers for the specific sequence, the kit shows high specificity than PCR which uses 2 primers for the sequence.
- High efficiency: Reaction time is quite shorter than usual PCR as 30mins or less, since not needing cyclic thermal change during the whole procedure. At the same time RNA loss reduces with isothermal environment, which enables high efficient amplification of nucleic acids.
- Convenience & Simplicity: Visual detection of results is accomplished by including dye into the mixture, users do not need to conduct extra electrophoresis for detecting amplified products.
Company news
Date
Topic
Download
Oct 8, 2020
Medical Device Exhibition 2019 in Düsseldorf, Germany-M monitor Inc.
As the spread of COVID-19 continues, overseas exhibitions around the world are unstable.
Why don't you take this crisis as an opportunity to check your experience in the exhibition and prepare what strategies to implement in the upcoming exhibition?
●Business Field: (Bio/Medical) R&D and production specialized in molecular diagnostics
●Main products and technology: COVID-19 detection kit
COVID-19 diagnostic kit that can amplify genes characteristic of the COVID-19 (SARS-CoV-2 virus) to check whether they are infected
- Possible to test multiple samples at the same time, so it can reduce costs
- Provides high accuracy, sensitivity, and accurate qualitative analysis
- Supports appropriate measures through rapid diagnosis
● Participated overseas exhibitions: Medical Device Exhibition (MEDICA) 2019 in Düsseldorf, Germany
Q1. What was your achievement at the fair?
In the bio-medical sector in Europe, Korean companies is in short supply. Therefore, there was also a lack of market research data, which was a good opportunity to understand the preferences of diagnostic devices and analyze medical trends through the fair. In addition, by collecting related product information other than the diagnostic kit, it was possible to understand the market status of the European region.
Q2. The situation is difficult with COVID-19, but how are you now?
We know that it is important not only to meet and promote customers in person at the fair, but also to discover potential buyers. At this time, we want to focus on this because we can continuously communicate with the discovered buyers and maximize the promotional effect by expanding the customer network. Currently, I think it is a stage of preparation because it is unclear to hold the fair due to Corona 19, and I am building trust and promoting products by communicating with various potential customers.
In addition, in order to understand the overall market trend, KOTRA is using market research and buyer search services through various support projects such as new export companies.
Why don't you take this crisis as an opportunity to check your experience in the exhibition and prepare what strategies to implement in the upcoming exhibition?
●Business Field: (Bio/Medical) R&D and production specialized in molecular diagnostics
●Main products and technology: COVID-19 detection kit
COVID-19 diagnostic kit that can amplify genes characteristic of the COVID-19 (SARS-CoV-2 virus) to check whether they are infected
- Possible to test multiple samples at the same time, so it can reduce costs
- Provides high accuracy, sensitivity, and accurate qualitative analysis
- Supports appropriate measures through rapid diagnosis
● Participated overseas exhibitions: Medical Device Exhibition (MEDICA) 2019 in Düsseldorf, Germany
Q1. What was your achievement at the fair?
In the bio-medical sector in Europe, Korean companies is in short supply. Therefore, there was also a lack of market research data, which was a good opportunity to understand the preferences of diagnostic devices and analyze medical trends through the fair. In addition, by collecting related product information other than the diagnostic kit, it was possible to understand the market status of the European region.
Q2. The situation is difficult with COVID-19, but how are you now?
We know that it is important not only to meet and promote customers in person at the fair, but also to discover potential buyers. At this time, we want to focus on this because we can continuously communicate with the discovered buyers and maximize the promotional effect by expanding the customer network. Currently, I think it is a stage of preparation because it is unclear to hold the fair due to Corona 19, and I am building trust and promoting products by communicating with various potential customers.
In addition, in order to understand the overall market trend, KOTRA is using market research and buyer search services through various support projects such as new export companies.
Apr 8, 2020
GC Green Cross MS signed a business agreement with M monitor Inc. for COVID-19 diagnostic kit
GC Green Cross announced on the 8th that it has signed a strategic business agreement with M monitor Inc, a POCT molecular diagnostic company, at the headquarters in Yongin, Gyeonggi-do on the 7th.
Under this agreement, the two companies will cooperate in various fields for overseas expansion of M monitor's COVID-19 diagnostic kit. GC Green Cross MS is in charge of product production and sales, and plans to promote new licenses for its own products through technology transfer.
This diagnostic kit is applied with'Isothermal Amplification Technology (LAMP)' that amplifies genes at a constant temperature without repeating heating and cooling. As a result, it is possible to shorten the analysis of the results from sample collection to within 1 hour. In addition, it is a feature of the product that the presence or absence of a virus can be immediately confirmed by the color change of the reagent.
The product line consists of two parts. These include a 'premix' kit with colorimetric technology applied and a 'real-time' kit using existing real-time monitoring equipment.
GC Green Cross MS is currently developing an ultra-sensitive COVID-19 diagnostic reagents using DNA polymerase technology targeting advanced medical countries. The rapid diagnosis product will be a good alternative to regions and countries where medical infrastructure is not sufficiently secured.
Under this agreement, the two companies will cooperate in various fields for overseas expansion of M monitor's COVID-19 diagnostic kit. GC Green Cross MS is in charge of product production and sales, and plans to promote new licenses for its own products through technology transfer.
This diagnostic kit is applied with'Isothermal Amplification Technology (LAMP)' that amplifies genes at a constant temperature without repeating heating and cooling. As a result, it is possible to shorten the analysis of the results from sample collection to within 1 hour. In addition, it is a feature of the product that the presence or absence of a virus can be immediately confirmed by the color change of the reagent.
The product line consists of two parts. These include a 'premix' kit with colorimetric technology applied and a 'real-time' kit using existing real-time monitoring equipment.
GC Green Cross MS is currently developing an ultra-sensitive COVID-19 diagnostic reagents using DNA polymerase technology targeting advanced medical countries. The rapid diagnosis product will be a good alternative to regions and countries where medical infrastructure is not sufficiently secured.
About us
Company details
M monitor Inc., founded in 2014, is one of the leading companies with high technologies based on nucleic acid isothermal amplification platform, develops and produces reagents and instruments for molecular diagnosis as well as research field. Our diagnostic products lead the paradigm of diagnosis in accuracy and speed aspects by combining with the advantages of both immuno-chemical diagnosis and molecular diagnosis methods.
Based on our platform technology, diagnostic products include various infectious pathogens such as respiratory diseases, sexually transmitted infections, mosquito mediated diseases as well as mutant viruses such as drug resistance bacteria. Also, we have a diverse portfolio in animal health, pathogen detection, molecular biology research.
All products are manufactured under GMP facilities and ISO 13485 or CE international regulation to meet the quality standards required by the global market. M monitor Inc is creating higher value with worldwide business opportunities and partnerships through continuous R&D and supreme quality products.
Based on our platform technology, diagnostic products include various infectious pathogens such as respiratory diseases, sexually transmitted infections, mosquito mediated diseases as well as mutant viruses such as drug resistance bacteria. Also, we have a diverse portfolio in animal health, pathogen detection, molecular biology research.
All products are manufactured under GMP facilities and ISO 13485 or CE international regulation to meet the quality standards required by the global market. M monitor Inc is creating higher value with worldwide business opportunities and partnerships through continuous R&D and supreme quality products.
Company data
Sales volume> 500 Mio US $
Export contentmax. 25%
Number of employees20-49
Foundation2014
Area of businessDiagnostics